We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Ticker | Name | Price | Change | Change % | Volume |
---|---|---|---|---|---|
AVTX | Avalo Therapeutics Inc | 20.662 | 15.91 | 334.99% | 18,511,603 |
XLO | Xilio Therapeutics Inc | 1.6292 | 0.9902 | 154.96% | 25,172,512 |
BDRX | Biodexa Pharmaceuticals PLC | 1.53 | 0.671 | 78.11% | 73,320,432 |
KYCH | Keyarch Acquisition Corporation | 11.66 | 4.65 | 66.44% | 36,979 |
CERO | CERo Therapeutics Holdings Inc | 2.4601 | 0.8301 | 50.93% | 2,956,754 |
OTRK | Ontrak Inc | 0.87 | 0.275 | 46.22% | 25,354,820 |
MESO | Mesoblast Limited | 4.94 | 1.45 | 41.55% | 7,961,004 |
PEGR | Project Energy Reimagined Acquisition Corporation | 11.9999 | 3.34 | 38.57% | 35,569 |
PIK | Kidpik Corporation | 4.46 | 1.19 | 36.39% | 8,540,273 |
VSTE | Vast Renewable Ltd | 3.10 | 0.79 | 34.20% | 19,737 |
NXL | Nexalin Technologies Inc | 1.0299 | 0.2499 | 32.04% | 1,856,529 |
Gilead Sciences, Inc. (Nasdaq: GILD) and Xilio Therapeutics, Inc. (Nasdaq: XLO) today announced an exclusive license agreement to develop and commercialize Xilio’s Phase 1 tumor-activated IL-12 program, XTX301.
SINGAPORE, March 28, 2024 /PRNewswire/ -- Primech Holdings Limited (Nasdaq: PMEC) ("Primech" or the "Company"), an established technology-driven facilities services provider in the public and private sectors operating mainly in Singapore, provides a financial and corporate update coincident with the filing of the Company's financial results for the six months ended September 30, 2023. These financial results are for periods prior to the Company's initial public offering ("IPO") in October of 2023.
Kidpik Corp. (NASDAQ: PIK) ("kidpik” or the "Company"), an online clothing subscription-based e-commerce company, today announced that the Company received written notification from the Listing Qualification Department of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that is has regained full compliance with the Minimum Bid Price Requirement.
Full Year Benefit of Maestro Acquisition and Q4 Corrective Actions Driving Financial Improvement TAMPA, Fla., March 26, 2024 /PRNewswire/ -- Marpai, Inc. ("Marpai" or the "Company") (Nasdaq: MRAI), an independent national Third-Party Administration (TPA) company transforming the $22 billion TPA market supporting self-funded employer health plans with affordable, intelligent healthcare, today announced financial results for the fourth quarter and fiscal year 2023. The Company expects to hold a webcast to discuss the results on March 27, 2024.
Rank | Ticker | Board Name | Posts (24h) |
---|---|---|---|
FNMA | Fannie Mae | 122 | |
COOP | Mr Cooper Group Inc | 55 | |
SFRX | Seafarer Exploration Corp | 81 | |
4 | CGAC | Code Green Apparel Corp | 146 |
5 | PSRU | Valiant Eagle Inc | 96 |
6 | RNVA | Rennova Health Inc | 75 |
Ticker | Name | Price | Change | Change % | Market Cap | Volume |
---|---|---|---|---|---|---|
BTC | Bitcoin | 70,909.70 | 1,450.81 | 2.09% | 1.4T | 7,581,295,332 |
ETH | Ethereum | 3,571.05 | 70.99 | 2.03% | 429.98B | 3,898,383,195 |
USDT | Tether USD | 1.00 | 0.00056 | 0.06% | 97.84B | 1,033,665,059 |
BNB | Binance Coin | 583.43 | 9.30 | 1.62% | 92.39B | 514,650,269 |
SOL | Solana | 186.27 | 0.150 | 0.08% | 82.56B | 1,683,514,224 |
STETH | stETH | 3,552.69 | 88.26 | 2.55% | 34.82B | 13,012,474 |
XRP | Ripple | 0.6208 | 0.0093 | 1.52% | 33.96B | 562,150,306 |
DOGE | Dogecoin | 0.21642 | 0.02638 | 13.88% | 31.1B | 2,845,453,404 |
USDC | USD Coin | 1.00 | 0.00 | 0.00% | 28.07B | 1,433,361,766 |
ADA | Cardano | 0.6523 | 0.0047 | 0.73% | 23.02B | 191,258,307 |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions